Kednapa Thavorn profile picture

Contact Information

Kednapa Thavorn, BPharm, MPharm, PhD
(613)-7378899 ext 72330

Research Administrative Assistant:
Jennifer Brownrigg
Telephone: 613-737-8899
Extension: 73810

ORCID logo

What We Do

HERO group's research themes
Lead by Dr. Kednapa Thavorn, the HERO group's primary fields of research are health economics, health technology assessment and health equity. Our goal is to combine our knowledge and experience in these areas to improve population health outcomes; reduce health care disparities in vulnerable and marginalized populations; and efficiently allocate health care resources.

HERO - Health Economics and healthcare Resource Optimization

Selected Publications

Papers in refereed journals: (N=247)

  1. Mahmoud HA*, Thavorn K, Mulpuru S, McIsaac D, Abdelrazek MA, Mahmoud AA, Forster AJ. Barriers and facilitators to improving patient safety learning systems: a systematic review of qualitative studies and meta-synthesis. BMJ Open Qual 2023 ;12(2):e002134. doi: 10.1136/bmjoq-2022-002134

  2. Mital S, Kelly D, Hughes C, Nosyk B, Thavorn K, Nguyen HV. Estimated cost-effectiveness of point-of-care testing in community pharmacies versus self-testing and standard laboratory testing for HIV. AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003526.

  3. Khan F*, Thavorn K, Coyle D, van Katwyk S, Tritschler T, Hutton B, Le Gal G, Rodger MA, Fergusson DA. Protocol for a Modelling Study to Assess the Clinical and Cost-Effectiveness of Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. BMJ Open. 2023;13(1):e053927. doi: 10.1136/bmjopen-2021-053927

  4. Kekre N, Hay KA, Webb JR, Mallick R, Balasundaram M, Sigrist MK, Clement AM, Nielsen JS, Quizi J, Yung E, Brown SD, Dreolini L, Waller DD, Smazynski J, Gierc NS, Loveless BC, Clark K, Dyer T, Hogg R, McCormick L, Gignac M, Bell S, Chapman DM, Bond D, Yong S, Fung R, Lockyer HM, Hodgson V, Murphy C, Subramanian A, Wiebe E, Yoganathan P, Medynski L, Vaillan DC, Black A, McDiarmid S, Kennah M, Hamelin L, Song K, Narayanan S, Rodrigo JA, Dupont S, Hawrysh T, Presseau J, Thavorn K, Lalu MM, Fergusson DA, Bell JC, Atkins H, Nelson BH, Holt RA. CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies. Front Immunol. 2022;13:1074740. doi: 10.3389/fimmu.2022.1074740

  5. Singh S, Tahsin F, Nie JX, McKinstry B, Thavorn K, Upshur R, Harvey S, Wodchis W, Gray CS. Exploring the perspectives of primary care providers on use of the electronic Patient Reported Outcomes tool to support goal-oriented care: A qualitative study. BMC Medical Informatics and Decision Making. 2021;21, 366. doi: 10.1186/s12911-021-01734-0

  6. Nochaiwong S, Ruengorn C, Awiphan R, Chai-Adisaksopha C, Sood MM, Hutton B, Thavorn K. Use of Serotonin Reuptake Inhibitor Antidepressants Concomitant with Antithrombotic Therapy and the Risk of Bleeding Complications: A Systematic Review and Meta-Analysis. Annals of Medicine. 2021;54(1):80-97. doi:  10.1080/07853890.2021.2017474 

Meet the HERO Dr Thavorn Group